SLC5A5 and neoplasm: We performed targeted transcriptome analysis using the Nanostring nCounter mouse immunology panel to gain insights into alternative immune-mediated mechanisms underlying initial response and subsequent tumor progression upon MV-NIS and anti-PD-1 combination treatment.